Clinical Trials
11 trialsNCT04166734 2026-02-04
MESO-PRIME
Royal Marsden NHS Foundation Trust
Phase 1 Terminated
NCT06439888 2025-12-01
LySATRA
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2 Recruiting
NCT02608385 2025-06-08
Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors
University of Chicago
Phase 1 Active not recruiting
NCT03399552 2023-10-23
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT05469490 2022-09-30
Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors
University of Pittsburgh
Phase 1 Withdrawn
NCT04407897 2022-04-28
SOFT
Herlev Hospital
Phase NA Unknown
NCT03220854 2022-01-10
SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx
Virginia Commonwealth University
Phase 2 Completed
NCT01752036 2020-06-25
Radiotherapy for Solid Tumor Spine Metastases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT01188486 2018-04-17
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Stanford University
Phase NA Terminated
NCT00311597 2017-03-14
Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors
Wake Forest University Health Sciences
Phase 1/2 Completed
NCT00938457 2016-05-19
Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
Mayo Clinic
Phase 1/2 Terminated